We have located links that may give you full text access.
Safety of thoracic magnetic resonance imaging for patients with pacemakers and defibrillators.
BACKGROUND: During magnetic resonance imaging (MRI), cardiac implantable electronic device (CIED) leads can be antennae to focus energy onto myocardium, leading to heating and arrhythmias. Clinical data on thoracic MRI safety for patients with legacy devices are limited.
OBJECTIVE: The purpose of this study was to identify patients undergoing thoracic MRI with legacy devices, compare the incidence of adverse events of those patients with control patients undergoing brain MRI with legacy devices, and compare paired cardiac troponin T (cTnT) values.
METHODS: In this single-center study, we reviewed a prospectively collected database of patients with CIED undergoing MRI from January 25, 2008, through February 28, 2017.
RESULTS: Of 952 patients (1290 scans), 120 patients (12.6%) underwent 134 thoracic MRI scans with legacy CIEDs (median [range] age 61.98 [21.24-86.96] years; male 71.1%). Median (range; interquartile range [IQR]) age of leads across devices was 3.5 (1.6-7.1; 5.5) years; implantable cardioverter-defibrillators (ICDs) were oldest (median [range; IQR], 3.7 [1.1-8.0; 6.9] years). No difference was observed in incidence of adverse events between groups. Paired cTnT values were compared for 19 patients (19 scans) with no difference between pre- and postimaging values. No significant difference was present in device setting values before and after MRI (mean follow-up 72.5 days). Incidence of adverse events was no different after adjustment for ICD coil number.
CONCLUSION: Thoracic MRI is relatively safe in an institutional multidisciplinary program. It does not represent greater risk than brain MRI for patients with legacy CIEDs.
OBJECTIVE: The purpose of this study was to identify patients undergoing thoracic MRI with legacy devices, compare the incidence of adverse events of those patients with control patients undergoing brain MRI with legacy devices, and compare paired cardiac troponin T (cTnT) values.
METHODS: In this single-center study, we reviewed a prospectively collected database of patients with CIED undergoing MRI from January 25, 2008, through February 28, 2017.
RESULTS: Of 952 patients (1290 scans), 120 patients (12.6%) underwent 134 thoracic MRI scans with legacy CIEDs (median [range] age 61.98 [21.24-86.96] years; male 71.1%). Median (range; interquartile range [IQR]) age of leads across devices was 3.5 (1.6-7.1; 5.5) years; implantable cardioverter-defibrillators (ICDs) were oldest (median [range; IQR], 3.7 [1.1-8.0; 6.9] years). No difference was observed in incidence of adverse events between groups. Paired cTnT values were compared for 19 patients (19 scans) with no difference between pre- and postimaging values. No significant difference was present in device setting values before and after MRI (mean follow-up 72.5 days). Incidence of adverse events was no different after adjustment for ICD coil number.
CONCLUSION: Thoracic MRI is relatively safe in an institutional multidisciplinary program. It does not represent greater risk than brain MRI for patients with legacy CIEDs.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app